What the OptumRx Litigation Means to Industry We have received a lot of questions over the past few weeks on how the lawsuit is progressing and what it will mean for the industry. Although we do not have any definitive answers yet (a court decision could come as early...
PBMs & Pharmacies, Episode V: States Strike Back The State of New York recently passed into law Assembly Bill A9507C, a seemingly mundane bill concerning “major components of legislation necessary to implement the state health and mental hygiene budget for the...
Will Independent Pharmacies Make It Against Amazon? Over the last 20 years, the pharmaceutical industry has completely changed due to consolidation – almost always to the detriment of independent pharmacies’ bottom line. Squeezing Profits Through Consolidation...
DEA Consultant Receives Public Backlash & New Developments Demetra Ashley spent three decades at the DEA specializing in the diversion of prescription drugs like OxyContin. Last spring, she left to start a consulting firm called Dashley Consulting, LLC. She has...
Big 3 Service Fees are an Opening for Amazon The Big 3 consolidated into the behemoths they are today through the 1990s and early 2000s. With so much volume being captured, the Big 3 gained the power to control the relationship they have with generic drug...
